Article abstract


Nature Medicine 13, 432 - 438 (2007)
Published online: 11 March 2007 | doi:10.1038/nm1555

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

Joseph El Khoury1,2, Michelle Toft1, Suzanne E Hickman1, Terry K Means1, Kinya Terada3, Changiz Geula4,5 & Andrew D Luster1


Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.

Top
  1. Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology. 149 13th Street, Charlestown, Massachusetts 02129, USA.
  2. Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, Massachusetts 02129, USA.
  3. Department of Neurological Surgery, Okayama University Medical School 2-5-1, Shikata-cho, Okayama 700–8558, Japan.
  4. Laboratory for Neurodegenerative and Aging Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
  5. Present address: Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, 320 East Superior Street, Searle 11-465, Chicago, Illinois 60611, USA.

Correspondence to: Joseph El Khoury1,2 e-mail: jelkhoury@partners.org

Correspondence to: Andrew D Luster1 e-mail: luster.andrew@mgh.harvard.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Immune cells may fend off Alzheimer disease

Nature Medicine News and Views (01 Apr 2007)

Immune cells may fend off Alzheimer disease

Nature Medicine News and Views (01 Apr 2007)

See all 8 matches for News And Views

Extra navigation

Subscribe to Nature Medicine

Subscribe

naturejobs

natureproducts


ADVERTISEMENT